Utilities of amide compounds

Details Utilities of amide compounds Utilities of amide compounds

2008-09-30

2008-09-30

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S341000, C514S342000, C514S357000, C544S328000, C544S331000, C544S333000, C546S309000

Reexamination Certificate

active

10489333

ABSTRACT:
Compounds having an activity to enhance the expression of apoAI are provided, which are used as medicaments.Compounds of formula (I):in which ring A and Ar1are independently a monocyclic or bicyclic aromatic carbocyclic group or aromatic heterocyclic group, each of which may be optionally substituted, or the like; R is a hydrogen or the like; Z is oxygen or the like; Y1and Y2are a hydrogen, a lower alkyl, or the like; n is an integer of 0 to 2; the broken line is the presence or absence of a bond; and the wavy line represents a cis- or trans-geometrical isomerism with respect to the double bond; are disclosed.

REFERENCES:
patent: 5712294 (1998-01-01), Robert et al.
patent: 5760066 (1998-06-01), Tang
patent: 5843947 (1998-12-01), Robert et al.
patent: 6060494 (2000-05-01), Faasch et al.
patent: 0 528 146 (1993-02-01), None
patent: 0 718 285 (1996-06-01), None
patent: 0 903 345 (1999-03-01), None
patent: 0 974 573 (2000-01-01), None
patent: 0 987 256 (2000-03-01), None
patent: 2 327 675 (1999-02-01), None
patent: 3-014568 (1991-01-01), None
patent: 04-128284 (1992-04-01), None
patent: 04128284 (1992-04-01), None
patent: 4-253974 (1992-09-01), None
patent: 6-041118 (1994-02-01), None
patent: 7-330764 (1995-12-01), None
patent: 11-147874 (1999-06-01), None
patent: 11-158133 (1999-06-01), None
patent: 11-171848 (1999-06-01), None
patent: 11-302254 (1999-11-01), None
patent: 2001-139550 (2001-05-01), None
patent: 2001-233767 (2001-08-01), None
patent: 97/09048 (1997-03-01), None
patent: 98/02412 (1998-01-01), None
patent: 99/07382 (1999-02-01), None
patent: 99/07669 (1999-02-01), None
patent: 99/24404 (1999-05-01), None
Arnall, F. “The Determination of the Relative Strengths of some Nitrogen Bases of the Aromatic Series and of some Alkaloids” Journal of the Chemical Society, vol. 117, pp. 835-839 (1920).
Mndzhoyan and Afrikyan, “Amides of the Pyridine and Thiazole Series” Izvest. Akad. Nauk Armyan, S. S. R., Ser. Khim. Nauk, vol. 10, pp. 143-156 (1957). With English Translation.
Yabuuchi, T. “Thiophene Derivatives. V. Syntheses of 3-Arylpropionamides” Chemical & Pharmaceutical Bulletin, vol. 8, pp. 169-172 (1960).
Calvert et al, “Synthetic and Mechanistic Investigations of the Reductive Electrochemical Polymerization of Vinyl-Containing Complexes of Iron(II), Ruthenium(II), and Osmium(II)” Inorganic Chemistry, vol. 22(15), pp. 2151-2162 (1983).
Robert et al, “Synthesis and Anti-Inflammatory Activity of 6-Amino-2,4-lutidine and their Precursors” Arzneitmittel Forschung, vol. 47(5), pp. 635-642 (1997) As Abstracted by Caplus.
Robert et al, “Synthesis and Anti-Inflammatory Activity of 6-Amino-2,4-lutidine and their Precursors” Arzneitmittel Forschung, vol. 47(5), pp. 635-642 (1997).
Mndzhoyan and Afrikyan, “Amides of the Pyridine and Thiazole Series” Izvest. Akad. Nauk Armyan. S. S. R., Ser. Khim. Nauk, vol. 10, pp. 143-156 (1957). As Abstracted by Caplus (STN).
J. M. Robert et al., “Synthesis and Anti-inflammatory Activity of Polyazaheterrocyclic Derivatives of 6-Amino-2,4-lutidine and Their Precursors”, Arzneim.-Forsch./Drug Res., 47 (I), pp. 635-642, 1997.
Svein Dueland, et al., “Cholesterol 7α-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells”, Journal of Lipid Research, vol. 38, pp. 1445-1453, 1997.
Edward M. Rubin et al., “Inhibition of early atherogenesis in transgenic mice by human apolipoprotein Al”, Lettes to Nature, vol. 353, pp. 265-267, 1991.
Andrew S. Plump et al., “Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse”, Proc. Natl. Acad. Sci., vol. 91, pp. 9607-9611, 1994.
Jean-Michel Robert et al., “Synthesis and Anti-inflammatory Activity of Polyazaheterocyclic Derivatives of 6-Amino-2,4-lutidine and Their Precursors”, Arzneim.-Forsch./Drug Res., vol. 47(I), pp. 635-642, 1997.
Akira Miyazaki et al., “Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits”, Arterioscler. Thromb. Vasc. Biol., vol. 15, pp. 1882-1888, 1995.
Kiyoto Goto et al., “Synthesis and Biological Activity of the Metabolites of Diethyl 4-[(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonate (NO-1886)”, Chem. Pharm. Bull., vol. 44(3), pp. 547-551, 1996.
William J. Mergens et al., “In Vitro Nitrosation of Methapyrilene”, Journal of Pharmaceutical Sciences, vol. 68, No. 7, pp. 872-832, 1979.

Affiliated with

Also associated with

Rating

Utilities of amide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Utilities of amide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Utilities of amide compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3904114